科源制药(301281.SZ)发布前三季度业绩，归母净利润3147.07万元，下降20.69%

Core Viewpoint - Key financial metrics for Koyuan Pharmaceutical indicate a decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company's operating revenue for the first three quarters reached 303 million yuan, representing a year-on-year decrease of 8.52% [1] - The net profit attributable to shareholders of the listed company was 31.47 million yuan, down 20.69% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 22.65 million yuan, reflecting a year-on-year decrease of 15.84% [1] - Basic earnings per share stood at 0.2906 yuan [1]